Effectiveness of GLP-1 medications for treating type 2 diabetes in young people
Official title: Real-world Effectiveness and Utilization of Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Type 2 Diabetes in Adolescents and Young Adults
Funded at Children's Hosp of Philadelphia · NIH-10825007 · Data updated 2026-11-12
This study looks at how well a type of diabetes medication called GLP-1 receptor agonists works for teenagers and young adults with type 2 diabetes, while also exploring the challenges they face in getting the treatment they need.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Hosp of Philadelphia NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $90,988 |
| NIH project number | 1F32DK138739-01 |
| Project ID | NIH-10825007 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescents and young adults aged 17 to 40 who are diagnosed with type 2 diabetes.
✕Less likely to help
Patients who are not diagnosed with type 2 diabetes or are older than 40 years may not benefit from this research.
What this research studies
This research investigates how effective glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are for managing type 2 diabetes in adolescents and young adults. It aims to understand their real-world usage compared to other diabetes treatments, particularly focusing on the challenges faced by young patients, including access issues and health disparities. By analyzing data from a large electronic health record database, the study will provide insights into how these medications perform in everyday clinical settings for younger populations.
Why it matters
Potential benefit: If successful, this research could improve treatment options and outcomes for young people with type 2 diabetes.
How similar studies have gone: Previous research has shown promising results with GLP-1 RAs in adult populations, but this specific focus on adolescents and young adults is relatively novel.
Where this research is happening
-
Children's Hosp of Philadelphia
Philadelphia, United States Active
Researchers
- Principal investigator: Chu, Patricia Yea — Children's Hosp of Philadelphia
- Study coordinator: Chu, Patricia Yea
Related research
Other NIH-funded projects on the same topics.
-
Subtyping Core for Research on the Causes of Type 2 Diabetes (SCORE-T2D)
A new U01 grant from a university research team aims to understand why Type 2 diabetes differs so much between people and how to tailor prevention and treatment.
-
Michigan Diabetes Project: A Peer-Led Self-Management Program for Adults with Type 2 Diabetes
A peer-led self-management program for adults with type 2 diabetes is being tested to see if it improves blood sugar control and daily diabetes care.
-
Alzheimer’s and dementia risk in people with prediabetes or type 2 diabetes
This grant aims to understand why some older adults with prediabetes or type 2 diabetes develop memory problems or dementia.
-
Personalized use of newer diabetes medicines for Type 2 diabetes
Aiming to tailor use of newer glucose-lowering drugs for people with type 2 diabetes to improve health and access in real-world settings.
-
Alzheimer’s and related dementia in older adults with prediabetes or type 2 diabetes
This grant aims to understand why cognitive problems occur in people 65 and older who have prediabetes or type 2 diabetes, using data from a long-running diabetes study to identify what drives memory and thinking decline.
-
Understanding why youth develop type 2 diabetes and how to prevent it
A nationwide study aims to unravel why some teens with obesity develop type 2 diabetes while others don’t, and to identify factors that could help prevent it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.